Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Need help?

Patient Help Centre

Remote monitoring for patients with, or at risk of diabetes

Self-monitoring of blood glucose levels

Patient Help Centre

DBm-Health is a patient to clinician system that helps health care professionals manage patients with diabetes or at risk of diabetes, and promotes self-care.

It is ideally suited to patients needing additional support to maintain safe blood glucose levels.

The need for safe remote monitoring during the COVID-19 pandemic

The COVID-19 pandemic has increased the need for digital technologies to help clinicians manage their patients remotely, reducing the risk to individuals who are particularly vulnerable to COVID-19 and are advised to shield during the pandemic.

Free smartphone app

Patients can input and share blood glucose readings and other relevant data (i.e. medication taken), and request a callback from their care team.

Clinician's desktop app

Patient lists can be filtered to help prioritise interventions; individual blood glucose readings can be viewed; and messages sent to patients via the app or by SMS.

Self-monitoring for patients

Self-help guides and a record of blood glucose readings in diary and graph format helps patients to actively manage their blood glucose levels.

DBm-Health is intended for adult patients with, or at risk of diabetes needing frequent blood glucose monitoring, including:

Patients new to insulin treatment needing enhanced diabetes support from their healthcare team
Cancer patients receiving high dose steroid treatment
Women with diabetes planning a pregnancy

Patients with type 1 diabetes not suited to continuous glucose monitoring (CGM)
Patients with coronavirus at risk of hyperglycaemia
Patients with type 2 diabetes requiring intensive support

Benefits

Patient communication

Frequent monitoring of readings and in-app messaging can facilitate improved communication and oversight

Increased service capacity

Complex cases can be managed more efficiently, freeing up capacity for more patients without increasing resources

Improved adherence

Easy-to-use apps can lead to more comprehensive reporting of blood glucose levels

Improved reliability

Replaces paper-based processes which are associated with poor data reliability

Faster audit

System reports replace time-consuming manual audit processes

Support for self-monitoring

User-friendly displays of historical readings and self-help guides empower patients to self-manage their condition

DBm-Health is classified as a Medical Device and is registered as such with the UK National Competent Authority (MHRA).

Note: Not all Sensyne Health products are available in all territories, for further information contact head office.

Download Product Guide

DBm-Health in the news

Blog

Innovative technology is making it easier for people with diabetes to manage their condition and for clinicians to deliver better care

September 24, 2021

Press release

Sensyne Health announces development of ‘DBm-Health™’ a new software product for people with or at risk of diabetes

August 19, 2020

FAQs

References

2019 surveillance of 4 diabetes guidelines – Consultation document. NICE https://www.nice.org.uk/guidance/ ng28/update/ng28-update-1/documents/surveillance-review-proposal
Kebede MM, Zeeb H, Peters M, Heise TL, Pischke CR. Effectiveness of Digital Interventions for Improving Glycemic Control in Persons with Poorly Controlled Type 2 Diabetes: A Systematic Review, Meta-analysis, and Meta-regression Analysis. Diabetes Technol Ther. 2018;20(11):767-782. doi:10.1089/dia.2018.0216

Sensyne Health Group Limited. registered in England and Wales No. 11240986 is a trading company of Sensyne Health plc registered in England and Wales No. 11425451

Registered office: Schrödinger Building, Heatley Road, Oxford Science Park, Oxford, OX4 4GE, United Kingdom.

Note: Not all Sensyne Health products are available in all territories, for further information contact head office.

In support of the ‘Understanding Patient Data’ initiative, Sensyne Health cite that its “work uses data provided by patients and collected by the NHS as part of their care and support”. #datasaveslives